A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1

被引:4
作者
Heaney, Alice [1 ]
Wilburn, Jeanette [1 ]
Langmead, Shannon [2 ]
Blakeley, Jaishri [2 ]
Huson, Susan [3 ]
Jim, Carly [4 ]
McKenna, Stephen P. [1 ,5 ]
机构
[1] Galen Res, B1 Chorlton Mill,3 Cambridge St, Manchester M1 5BY, Lancs, England
[2] Johns Hopkins Comprehens Neurofibromatosis Ctr, Baltimore, MD USA
[3] St Marys Hosp, Manchester Ctr Genom Med, Manchester, Lancs, England
[4] Manchester Metropolitan Univ, Dept Psychol, Manchester, Lancs, England
[5] Univ Manchester, Sch Hlth Sci, Manchester, Lancs, England
来源
SAGE OPEN MEDICINE | 2019年 / 7卷
关键词
Needs; qualitative; needs assessment; quality of life; plexiform neurofibromas; PlexiQoL; OF-LIFE; PARENTAL REPORTS; CROHNS-DISEASE; HEALTH-CARE; CHILDREN; ADOLESCENTS; PREVALENCE; DEPRESSION; MANAGEMENT; SYMPTOMS;
D O I
10.1177/2050312119829680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To explore the impact of plexiform neurofibromas on the lives of adults with neurofibromatosis type 1. Background: Neurofibromatosis type 1 is a complex neurogenetic syndrome that affects many aspects of health and functioning. A common manifestation of neurofibromatosis type 1 is plexiform neurofibromas, non-cancerous tumours that can cause disfigurement, pain and neurologic disability. Patient-reported outcome measures used in this condition have addressed symptoms and functional ability but not how the condition affects patients' lives, particularly, their ability to meet their human needs. Methods: Unstructured qualitative interviews were conducted with adults with neurofibromatosis type 1-associated plexiform neurofibromas in the United Kingdom and United States. Interviewees were encouraged to describe how plexiform neurofibromas affected their ability to meet their needs. Interviews were audio-recorded and transcribed verbatim. The UK and US transcripts were combined and theoretical thematic analysis was conducted. Results: In all, 42 interviews (United Kingdom = 20, United States = 22) were conducted. Transcripts revealed 696 statements on the impact of plexiform neurofibromas on need fulfilment. Five major themes emerged: appearance, relationships, independence, role fulfilment and pleasure. Conclusion: Neurofibromatosis type 1-associated plexiform neurofibromas have a major effect on individuals' ability to meet their needs. An understanding of need fulfilment will complement information generated from traditional patient-reported outcome measures, particularly in a multi-faceted syndrome such as neurofibromatosis type 1.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
    Robertson, Kent A.
    Nalepa, Grzegorz
    Yang, Feng-Chun
    Bowers, Daniel C.
    Ho, Chang Y.
    Hutchins, Gary D.
    Croop, James M.
    Vik, Terry A.
    Denne, Scott C.
    Parada, Luis F.
    Hingtgen, Cynthia M.
    Walsh, Laurence E.
    Yu, Menggang
    Pradhan, Kamnesh R.
    Edwards-Brown, Mary K.
    Cohen, Mervyn D.
    Fletcher, James W.
    Travers, Jeffrey B.
    Staser, Karl W.
    Lee, Melissa W.
    Sherman, Marcie R.
    Davis, Cynthia J.
    Miller, Lucy C.
    Ingram, David A.
    Clapp, D. Wade
    LANCET ONCOLOGY, 2012, 13 (12) : 1218 - 1224
  • [32] Psychological Distress in Adults with Neurofibromatosis Type 1: A Longitudinal Study
    Reichardt, Christoph
    Scherwath, Angela
    Mautner, Victor Felix
    Bullinger, Monika
    Petersen-Ewert, Corinna
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2013, 63 (02) : 85 - 92
  • [33] Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood
    Sally E. Jensen
    Zabin S. Patel
    Robert Listernick
    Joel Charrow
    Jin-Shei Lai
    Journal of Clinical Psychology in Medical Settings, 2019, 26 : 259 - 270
  • [34] Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity
    Loucas, Caitlyn
    Wolters, Pamela
    Toledo-Tamula, Mary Anne
    Rhodes, Amanda
    Baldwin, Andrea
    Goodwin, Anne
    Widemann, Brigitte
    Martin, Staci
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2022, 38 : 7 - 12
  • [35] An evaluation of selumetinib for the treatment of neurofibromatosis type 1-associated symptomatic, inoperable plexiform neurofibromas
    Metrock, Laura K.
    Lobbous, Mina
    Korf, Bruce
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (04): : 239 - 246
  • [36] Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
    Kim, AeRang
    Dombi, Eva
    Tepas, Kathleen
    Fox, Elizabeth
    Martin, Staci
    Wolters, Pamela
    Balis, Frank M.
    Jayaprakash, Nalini
    Turkbey, Baris
    Muradyan, Naira
    Choyke, Peter L.
    Reddy, Alyssa
    Korf, Bruce
    Widemann, Brigitte C.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (03) : 396 - 401
  • [37] The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1
    Dance, Brieana
    Dardare, Alice
    Fleming, Jane
    Siow, Sue-Faye
    Schlub, Timothy E.
    Crawford, Hilda
    Saunderson, Rebecca B.
    Wong, Claire
    Berman, Yemima
    JOURNAL OF DERMATOLOGY, 2024, 51 (08) : 1050 - 1059
  • [38] Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study
    Suenobu, Souichi
    Terashima, Keita
    Akiyama, Masaharu
    Oguri, Tomoyo
    Watanabe, Asako
    Sugeno, Masatoshi
    Higashimori, Mitsuo
    So, Karen
    Nishida, Yoshihiro
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [39] Treatment, Resource Use and Costs Among Pediatric Patients with Neurofibromatosis Type I and Plexiform Neurofibromas
    Yang, Xiaoqin
    Desai, Kaushal
    Agrawal, Neha
    Mirchandani, Kirti
    Chatterjee, Sagnik
    Sarpong, Eric
    Sen, Shuvayu
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2020, 11 : 421 - 428
  • [40] Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life
    Cohen, J. S.
    Levy, H. P.
    Sloan, J.
    Dariotis, J.
    Biesecker, B. B.
    CLINICAL GENETICS, 2015, 88 (05) : 425 - 430